AGC Biologics to Manufacture Teikoku’s rhMMP-7
HEIDELBERG, Germany and CHIBA, Japan, May 26, 2026 HEIDELBERG, Germany and CHIBA, Japan, May 26, 2026 — AGC Biologics...
Alzheimer’s Disease ASCO 2026 Autoimmune Disease Bio-Pharma biologics biopharma biopharma innovation Biotechnology Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development FDA fda approval FDA clearance GCP Gene Therapy Healthcare Innovation Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody NSCLC Oncology oncology innovation oncology research Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 trial Precision Medicine Precision Oncology rare disease rare diseases Regenerative Medicine regulatory compliance targeted therapy
HEIDELBERG, Germany and CHIBA, Japan, May 26, 2026 HEIDELBERG, Germany and CHIBA, Japan, May 26, 2026 — AGC Biologics...
HUNTSVILLE, Ala. and KASSEL, Germany, May 20, 2026 Discovery Life Sciences has launched Luminos® Comprehensive, a next-generation IVDR-compliant clinical...
JERUSALEM, Israel, May 20, 2026 Scinai Immunotherapeutics Ltd. has announced the appointment of Eilon Elmalem as the new Site...
